iNtRON Biotechnology, Inc. (KOSDAQ: A048530)
Health Care · Biotechnology · KR
₩2,745.00
+4.17% today · -28.8% 1Y
iNtRON Biotechnology, Inc. (KOSDAQ: A048530) operates in the Biotechnology industry within the Health Care sector. The company is valued at $61.19M.
Over the last twelve months the share price has lost 28.8%, trading between 2.25K and 7.01K.
Tweenvest scores iNtRON Biotechnology, Inc. across four factors: quality 55/100, value 64/100, growth 0/100. Its strongest factor is value.
A048530 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $61.19M
- Revenue (TTM)
- $3.98M
- P/E
- —
- EPS
- -282.94
- Dividend yield
- —
- Beta (5Y)
- 0.06
- 52-week high
- ₩7,010.00
- 52-week low
- ₩2,250.00
- Avg volume (3M)
- —
- Shares outstanding
- 30.89M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $261.26 | -1.70% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $439.02 | -0.73% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $147.48 | -0.87% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $547.02 | -1.05% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $825.08 | -1.02% |
| argenx SEENXTBR: ARGX | $64.17B | €895.40 | +1.84% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $150.71 | -5.11% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.